Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-06-03 @ 8:49 PM
Study NCT ID:
NCT00304005
Status:
COMPLETED
Last Update Posted:
2013-07-18
First Post:
2006-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders
Sponsor:
Vion Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
VION-CLI-041
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None